-
Mashup Score: 0
During the 16th International Conference on Malignant Lymphoma (16-ICML), the Lymphoma Hub spoke with Martine Bagot, Hôpital Saint-Louis, Paris, FR. We asked, Lacutamab for advanced mycosis fungoides: Are the early results promising?
Source: lymphomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Registration - 3 year(s) ago
Country
Source: register.gotowebinar.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
It’s a week until the post-EHA/ICML #CLLSession with Paolo Ghia, Susan O’Brien, Lydia Scarfo and @Othman_Al_Sawaf 🖥 🗓 Mon 26 July at 7pm CEST/6pm BST/1pm EDT📊 Follow this link to register: https://t.co/lJFEXLrj5Y @VJHemOnc #VJSessions #CLLsm #Leusm #EHA21 #16ICML https://t.co/CIeQSFLv1E
-
-
Mashup Score: 0
During the 16th International Conference on Malignant Lymphoma (16-ICML), the Lymphoma Hub spoke with Björn Chapuy, Universitätsmedizin Göttingen, Göttingen, DE, and Leticia Quintanilla-Martinez de Fend, University Hospital Tübingen, Tübingen, DE.
Source: lymphomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🎧 #16ICML | @lymphomahub spoke with Björn Chapuy, Universitätsmedizin Göttingen, and Leticia Quintanilla-Martinez de Fend, @uktuebingen. We asked, What is the role of genetic classification in the diagnosis of #DLBCL 👉 https://t.co/LNGI1lo2IY 👈 #lymsm #lymphoma https://t.co/vVmyXqyM5k
-
-
Mashup Score: 6Do the results of the LYSA LNH 09-1B trial support a PET-adapted treatment strategy for DLBCL? - 3 year(s) ago
During the 16th International Conference on Malignant Lymphoma (16-ICML), the Lymphoma Hub spoke with Hervé Tilly, Centre Henri-Becquerel, Rouen, FR. We asked, Do the results of the LYSA LNH 09-1B trial support a positron emission tomography (PET)-adapted treatment strategy for DLBCL?
Source: lymphomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
👀 At the #16ICML @lymphomahub spoke with @TillyHerve, @CentreBecquerel. We asked, Do the results of the LYSA LNH 09-1B trial support a positron emission tomography (PET)-adapted treatment strategy for #DLBCL? 👉 https://t.co/ZHmEumOtFe 👈 #lymsm #lymphoma https://t.co/KUDCN1splF
-
-
Mashup Score: 0Registration - 3 year(s) agoSource: register.gotowebinar.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Join us for a post-EHA/ICML #CLLSession with Paolo Ghia, Susan O’Brien, Lydia Scarfo and @Othman_Al_Sawaf 🖥 🗓 Mon 26 July at 7pm CEST/6pm BST/1pm EDT📊 Follow this link to register: https://t.co/Bg64fpWoeT @VJHemOnc #VJSessions #CLLsm #Leusm #EHA21 #16ICML https://t.co/iFKUuzze3k
-
-
Mashup Score: 0Registration - 3 year(s) ago
Country
Source: register.gotowebinar.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Join us for a post-EHA/ICML #CLLSession with Paolo Ghia, Susan O’Brien, Lydia Scarfo and @Othman_Al_Sawaf 🖥 🗓 Mon 26 July at 7pm CEST/6pm BST/1pm EDT📊 Follow this link to register: https://t.co/b9JcPWnRX4 @VJHemOnc #VJSessions #CLLsm #Leusm #EHA21 #16ICML https://t.co/OqipgxEbuY
-
-
Mashup Score: 0Registration - 3 year(s) agoSource: register.gotowebinar.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
It’s two weeks until the post-EHA/ICML #LymphomaSession with @gilles_salles @niravshahmd Ulrich Jäger and Stephen Ansell! 🗓 Thurs 29 July at 7pm CEST/6pm BST/1pm EDT📊 Follow this link to register: https://t.co/kzWeq9OIkQ @VJHemOnc #VJSessions #Lymsm #EHA21 #16ICML https://t.co/6ZiWf78WYz
-
-
Mashup Score: 0How have radiotherapy fractionation schemes evolved for the treatment of indolent lymphomas? - 3 year(s) ago
During the 16th International Conference on Malignant Lymphoma (16-ICML), the Lymphoma Hub spoke with Joachim Yahalom, Memorial Sloan Kettering Cancer Center, New York, US. We asked, How have radiotherapy fractionation schemes evolved for the treatment of indolent lymphomas?
Source: lymphomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
👀 At the #16ICML @lymphomahub spoke with @AchyYahalom, @sloan_kettering. We asked, How have radiotherapy fractionation schemes evolved for the treatment of indolent lymphomas? 👉 https://t.co/QKkdvqUMet 👈 #lymsm #lymphoma https://t.co/M6UCBFKwDS
-
-
Mashup Score: 0Registration - 3 year(s) agoSource: register.gotowebinar.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
It’s two weeks until the post-EHA/ICML #LymphomaSession with @gilles_salles, @niravshahmd, Ulrich Jäger and Stephen Ansell! 🗓 Thurs 29 July at 7pm CEST/6pm BST/1pm EDT📊 Follow this link to register: https://t.co/utVa2taug9 @VJHemOnc #VJSessions #Lymsm #EHA21 #16ICML https://t.co/7EmDnsAAjG
-
-
Mashup Score: 0Registration - 3 year(s) ago
Required field First Name Last Name …
Source: register.gotowebinar.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
It’s two weeks until the post-EHA/ICML #CLLSession with Paolo Ghia, Susan O’Brien, Lydia Scarfo and @Othman_Al_Sawaf 🖥 🗓 Mon 26 July at 7pm CEST/6pm BST/1pm EDT📊 Follow this link to register: https://t.co/2viYA1umO4 @VJHemOnc #VJSessions #CLLsm #Leusm #EHA21 #16ICML https://t.co/AaMmyJsJv5
-
👀 At the #16ICML @lymphomahub spoke with Martine Bagot, @HopSaintLouis. We asked, Lacutamab for advanced mycosis fungoides: Are the early results promising? 👉https://t.co/PYZ1QvWuL5 👈 #lymsm #lymphoma https://t.co/qrlGJjR3pB